Multiple System Atrophy: Clinical Trials

3 trials for Multiple System Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 2, Unknown 1

Follow Multiple System Atrophy: new trials by email Literature Review of Multiple System Atrophy trials Research Report on Multiple System Atrophy

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Parkinson's And Zoledronic Acid
Zoledronic Acid 5Mg/Bag 100Ml Inj, Placebo - Parkinson Disease, Osteoporosis
Phase 4CompletedCalifornia Pacific Medical Center Research Institute27212019-11-152026-06-25
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Droxidopa capsules, Placebo capsules - Symptomatic Neurogenic Orthostatic Hypotension
Phase 4CompletedH. Lundbeck A/S4532016-02-112023-08-23
Botulinum A Toxin in Patients With Parkinson's Disease
Intravesical injection of Botulinum A toxin - Parkinson's Disease, Multiple System Atrophy
Phase 4UnknownUniversity Of Perugia202008-06-012009-01-15

Narrower conditions

Parkinson Disease (3)  ·  Fractures, Bone (1)  ·  Lewy Body Disease (1)  ·  Osteoporosis (1)  ·  Parkinsonian Disorders (1)  ·  Pure Autonomic Failure (1)  ·  Supranuclear Palsy, Progressive (1)  ·  Urinary Bladder, Overactive (1)  ·  dopamine beta hydroxylase deficiency (1)

Broader conditions

Autonomic Nervous System Diseases (3)  ·  Basal Ganglia Diseases (3)  ·  Brain Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Movement Disorders (3)  ·  Nervous System Diseases (3)  ·  Neurodegenerative Diseases (3)  ·  Primary Dysautonomias (3)  ·  Synucleinopathies (3)  ·  Parkinsonian Disorders (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Cranial Nerve Diseases (1)

Interventions

Droxidopa (1)  ·  Idoxuridine (1)  ·  Zoledronic Acid (1)

Sponsors

California Pacific Medical Center Research Institute (1)  ·  H. Lundbeck A/S (1)  ·  University Of Perugia (1)

Countries

United States (2)

Top investigators

Antonella Giannantoni, M.D. (1)  ·  Steve Cummings, MD (1)

Results publications

PMID 33649343, PMID 35107750

NIH funding

R01AG059417 (1)